Most people accept the claims that two COVID vaccines are 95% effective and the US economy will soon be booming.
Due diligence:
I have never taken a flu vaccine in my life, and have never had the flu. I have no intention of getting a COVID vaccine, because they were rushed to market, with medium term and long term side effects completely unknown.
You may want to consider sharing this article with friends, whether or not they have had a COVID vaccine. They should know what the vaccine is expected to do, what it does not do, and the many unanswered questions.
2. Did you know it usually takes 5 to 10 years to fully develop a vaccine, not nine months?
3. Did you know the Covid19 vaccine is based on a new technology, which has never been approved for use on humans before?
4. Did you know drug companies can’t be sued if their Covid19 vaccine hurts or kills someone?
5. Did you know 99.8% of infected people survive Covid19 without a vaccine?
Summary:
The COVID vaccines ...
were rushed to market, and barely tested,
have unknown effectiveness with new Covid19 variants,
do not prevent you from getting infected with Covid19,
are made using a new technology,
have unknown medium-term and long-term side effects,
there is no legal recourse if they harm you,
all this for a virus that 99.8% of people will survive with no vaccine.
I've chosen to avoid this huge medical experiment.
My summary of the original article follows:
" ... Two (COVID vaccine) formulations have received interim approval from the FDA, and Health Canada: Pfizer/BioNtech and Moderna.
Both these injections (use) ... synthetic gene therapy (SGT), which is being dispensed to the populace for the first time in human history.
Medications are given to sick people to treat disease.
Vaccines are given to healthy people to prevent an infection.
Therefore consideration of risk-benefit analysis is paramount.
Covid is the umbrella label for PCR “positive” people regardless of clinical presentation.
Most are “asymptomatic,” some have generic cold/flu symptoms, and a few present with moderate or severe respiratory distress.
Unfortunately, the PCR assays being used for diagnosis, are not fit for that purpose.
Most PCR assays are constructed based on the German Drosten et al. protocol.
On November 27th 2020, 22 scientists submitted a request for retraction of this protocol which was published in the journal Eurosurveillance, citing a number of fatal design flaws.
... The first metric which every medical doctor must convey to a person is how deadly Covid actually is.
... all Covid death stats are inflated: under direction of the WHO, deaths ‘from” and incidentally “with” Covid are not distinguished.
Death coding has changed compared to Influenza/Pneumonia.
... this has resulted in ... inflation of death statistics
... The median age of Covid deaths (86) exceeds average life expectancy in Canada.
Tragically, 70% of the deaths in the province of Ontario took place in care homes.
The mortality rate from Covid in Canada under 59 years of age is 0.0017%.
According to the CDC, the survival from Covid (with inflated stats) is as follows:
(under 20) 99.997%,
(29-49) 99.98%,
(50-69) 99.5% and
(over 70), 94.6%.
The Covid synthetic gene therapy injections employ synthetic, thermostable nucleotide sequences which are wrapped in a PEG (polyethylene glycol)-lipid nanoparticles to protect from destruction in the bloodstream and facilitate entry into the cells.
The claim is that the cellular machinery will engage with these synthetic sequences and produce segments which code for the SarsCov2 S1 spike protein.
It is believed that the immune system will mount a sufficient antibody response.
... These therapies do not prevent infection, merely reduction in one or more symptoms.
... Media outlets, politicians, and public health officials have blared the 95% efficacy for both formulations.
To the casual observer, this would denote 95% reduction in hospitalizations or deaths.
... the 95% is calculated, based upon the “Primary Efficacy Endpoints.”
... these endpoints are described by both companies as non-severe cold/flu SYMPTOMS coupled with a positive PCR.
... in both trials, once one/two symptoms appeared in a participant, it was designated a “case” or “event” when coupled with a positive PCR “test”.
Once 170 “cases” occurred in Pfizer/BioNtech trial, and 196 “cases” occurred in Moderna trial, this data was used to calculate efficacy.
Shockingly ... under 200 cases for a novel therapy which is being deployed/subjected on millions of people around the world.
... people are not being informed that “95%” or so efficacy, is calculated based on a useless metric of relative efficacy and is therefore very misleading.
162 “cases” in placebo group
8 "cases" in injection group
8/162 = 5%
100%-5%= 95%
... they are claiming that the synthetic gene therapy injections are 95% efficacious.
What they are not factoring in is the size of the denominator.
... This is the absolute risk reduction for Pfizer/BioNtech, each group had over 18,000 people!
Injection Group: 8/18,198 = 0.04%
Placebo Group: 162/18,325= 0.88%
... the absolute risk reduction ... is 0.84%. (ie. 0.88-0.04)
This means, that someone who takes the Pfizer/BioNtech injection, has less than 1% chance of reducing at least one symptom of non-severe “Covid” for a period of 2 months.
This means that someone who takes this injection has over 99% chance that it won’t work, regarding the efficacy.
Over 100 people have to be injected for it to “work” in one person.
... There are many issues with the trial data, and design.
It must be noted that PCR tests are not fit for this purpose, and without Sanger sequencing we have no idea how many of these people actually had “Covid” vs another respiratory virus, or something else.
... Approximately 5-6 symptoms listed as “side effects” are the same as Covid symptoms.
Pfizer/BioNtech only started counting “cases” one week after the second dose, and Moderna, 2 weeks after the second dose.
... if these side effects were labelled as “Covid” symptoms ... the injected group may have been sicker with “Covid” more than the placebo group.
There have been many critiques of the applicability of the limited data to the general populace, especially the vulnerable elderly.
An important analysis of this was done by Dr James Lyons-Weiler who discovered the general population is dying at a rate 6.3 times the rate of participants in the Moderna trial (including placebo and injection groups).
"If Moderna’s on-vaccine death rate is so far below the national death rate and also simultaneously more than five times greater than Pfizer’s on-vaccine death rate, then Pfizer’s study sample appears even less representative of the entire population."
An integral question as to whether Pfizer/BioNtech and Moderna recruited supermen and women for their trials, comes to mind.
The incidence of “severe” Covid in Placebo groups which scrutinizing the details, wasn’t necessarily severe presentation, is so low that trials of 30,000-40,000 lacked statistical power to determine reductions in hospitalizations and deaths, according to Tal Zaks, CMO Moderna.
... the incidence of severe “Covid” was only 0.04% in Pfizer/BioNtech and 0.22% in Moderna.
Due to this very low attack rate of severe presentation in the population, the absolute risk reduction in severe presentation, even taking data at face value, is nominal.
... potential SGT recipients must be informed that to reduce “severe” presentation, chances are over 99.5% that these synthetic gene therapies will not work.
The British Medical Journal has reported: "Hospital admissions and deaths from covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30 000 people.
The same is true of its ability to save lives or prevent transmission: the trials are not designed to find out.”
... Up to 80% of injected trial recipients experienced side effects ...
The incidences of immediate side effects in both trials were significant and dwarfed the absolute risk reduction in both the primary efficacy endpoints, as well as for “severe” Covid.
For example, for Moderna 81.9% experienced a systemic reaction.
Grade 3 reactions (considered severe) were experienced by 17.4%.
This is 79X more likely than the incidence of severe Covid in the Moderna group. (17.4/.22=79X)
Based on preliminary reports of adverse events:
"This is an injury rate of 1 in every 40 jabs.
This means that the 150 shots necessary to avert one mild case of COVID will cause serious injury to at least three people.“
The safety data for both companies is approximately only two months before receiving emergency use authorization status.
... there are no data for mid-long term side effects, as the trials are ongoing.
The estimated completion date for Pfizer/BioNtech trials is Jan 31, 2023.
The estimate completion date for Moderna trials is October 27, 2022.
According to the data, and elaborated by Tal Zaks (CMO of Moderna) the trials are not designed to demonstrate a reduction in transmission, due to “operational realities”.
It is therefore baffling how medical doctors and public health officials are proclaiming these SGTs will promote herd immunity.
The manufacturers have also made it clear that efficacy beyond 2 months or so is unknown.
... the 1% absolute risk reduction in mild/moderate, cold/flu symptoms may not last more than a few months.
... Health Canada approved this experimental SGT on the populace without even 6 months of trial data.
... New vaccines typically take about 7 to 20 years of research and trials before going to market.
Pfizer/Moderna ran all of their trials simultaneously, including their animal trials, instead of sequentially.
As retired Health Canada research scientist, Dr Qureshi, elaborated, it is during proper animal trials that meaningful toxicology data is obtained.
The anaphylactic reactions observed in some people is also worrisome, worthy of analysis.
Children’s Health Defense submitted a request to the FDA to address PEG allergies, as up to 70% of the populace has antibodies to these compounds.
PEG has never been a component in a vaccine before.
It must also be noted that according to an internal Health Human Services and Harvard study, less than 1% of vaccine side effects are reported.
(with a) high level of immediate side effects, and low IFR (death rate) for Covid, there is already enough reason for concern.
... In previous SARS, MERS, Dengue fever and RSV virus vaccine trials, the exposure of wild viruses to vaccine recipients resulted in severe disease, cytokine storms, and deaths in some animal and human trials.
The phenomenon ... did not present initially in vaccine recipients, rather it presented after vaccine recipients were exposed to wild viruses.
This is the reason we do not have a vaccine for the common cold, MERS and SARS which is 78% homologous with SarsCov2 (based on analysis of the digital genome).
Immunology Professor Dolores Cahill warned that this disease enhancement may cause many vaccine recipients to die months or years down the road.
... Unfortunately, no vaccines for any of the known human CoVs have been licensed, although several potential SARS-CoV and MERS-CoV vaccines have advanced into human clinical trials for years, suggesting the development of effective vaccines against human CoVs has always been challenging.”
Traditional vaccines involve injection of the pathogen/toxin in whole/part to elicit an immune reaction.
For the first time in history, the recipients’ cells will manufacture the pathogen, the S1 spike protein of SarsCov2 virus.
... based on a couple of months of safety data, we do not know that these mRNAs last long enough to manufacture the protein but not long enough to exert deleterious effects.
... the RNA sequences are synthetic.
Therefore, we do not know how long they will last in the cells.
Dr Judy Mikovits has expressed concerns in that they may not be degraded immediately, and perhaps linger for days, months, years.
Moderna previously tried to use this same technology to treat Crigler-Najjar syndrome, and was not able to strike the balance between therapeutic dose and toxic side effects.
... what happens if the mRNA degrades too slowly, or not at all?
What happens when you turn your body into a “viral protein factory”, thus keeping antibody production activated on a continual basis with no ability to shut down?
... We have lots of enzymes (RNAses and DNAses) that degrade free RNA and DNA because ... those are danger signals to your immune system.
They literally drive inflammatory diseases.
Moderna boldly claims that these synthetic mRNAs will not integrate with the host cell DNA.
(but) There is the potential for this synthetic RNA to integrate into human DNA via the enzyme, reverse transcriptase.
This may lead to mutagenesis, possibly cancer.
It may lead to birth defects if it integrates into the germ cells of the injected.
Reassurances cannot be made based on such limited safety data.
... it is important to clearly understand the potential risks of this type of mRNA-based vaccine .., ”
... we are in the nascent stages of understanding the complex field of epigenetics.
... The manufacturers give the caveat:
"It is unknown whether COVID-19 mRNA Vaccine BNT162b2 has an impact on fertility. And women of childbearing age are advised to avoid pregnancy for at least two months after their second dose.”
Pregnant women were not included in either of the trials.
Trial recipients were instructed to use birth control.
... On social media, there have been many documented cases of bizarre neurologic symptoms in the SGT recipients.
... We now have a therapy that uses the body’s own cells to produce unknown (perhaps continuous) levels of a protein that is almost identical to Syncytin-1.
This is potential for disaster, as Dr Mikovits elaborated:
... Heart attacks are another documented side effect.
Loved ones of the deceased have shared on social media that these deaths are not considered vaccine reactions, and are therefore not recorded as such.
Cardiothoracic surgeon and researcher, Dr Hooman Noorchashm, wrote a letter of warning to the FDA.
His concern, the spike protein will cause inflammation, clot formation and heart attacks in SGT recipients who previously were exposed to SarsCov2:
"So if a person with a recent or active COVID-19 infection is vaccinated, the highly effective and antigen specific immune response incited by the vaccine will, very likely, attack the inner lining of the blood vessel and cause damage, leading to blood clot formation.
This could result in major serious problems like strokes and heart attacks, at least in some people ... "
... There are many avenues of potential harm and death, many are unknown as this experiment is only a few months old.
In contemplation of risk-benefit analysis, one must also consider low-risk ... treatments.
...vitamin D deficiency is linked to presentation of severe respiratory distress, and cytokine storm sequelae, which also includes Covid.
... All the risk factors for Covid are also risk factors for vitamin D deficiency.
We have a pandemic of vitamin D deficiency in many temperate climates.
Over two hundred scientists urged consideration of vitamin D supplementation for prevention and treatment of Covid.
... Chinese health officials have recommended a moratorium on these SGT Covid injections, after the investigations of deaths in care homes in Norway.
... On Feb 5th, the UK Medical Freedom Alliance penned a letter to Boris Johnson, urging him to address the post-injection vaccine deaths in care homes:
"We now call for an immediate and urgent audit of deaths that have occurred since the beginning of the Covid-19 vaccine rollout, to ascertain if Covid-19 vaccines (in general or any one brand in particular) are leading to an increased number of deaths (Covid-19 and non-Covid-19 related), Covid19 cases or increased risk of death in certain age groups or cohorts.”
There are now over 900 deaths in VAERS registry.
... these are likely a small percentage of actual deaths.
... people are not being informed that Phase 3 trials are ongoing.
The FDA and Health Canada have not approved these injections for licensure.
The injections are highly experimental.
These SGTs were designed and “assessed” at a record speed of less than a year and then given interim approval based on 2 months of safety data.
Recently, the Indian government declined the Pfizer SGT ...
... Dr Michael Yeadon, former Vice-President of Pfizer has also stated [emphasis added]:
"All vaccines against the SARS-CoV-2 virus are by definition novel.
If any such vaccine is approved for use under any circumstances that are not EXPLICITLY experimental, I believe that recipients are being misled to a criminal extent.”
The American Frontline Doctor’s white paper reports,
"An Experimental Vaccine Is Not Safer Than a Very Low IFR (COVID death rate)”
"To exercise informed consent, any recipient of this SGT must be made aware that they are now participating in a clinical trial."
There is no claim about reduction of transmission.
All risk-benefit analysis must be focused on the individual, as is treatment with a drug therapy.
Therefore, the potential trial recipient must understand IFR (death rate of COVID), the absolute risk reduction in symptoms, and potential side effects ...
... There is a substantial body of experts around the world, warning about the potential disasters of this novel SGT. "
... The new normal breeds hysteria, “safe and effective” are the cacophonous mantras.
Only a heretic dare analyze the actual data or initiate rational query.
The unscrupulous message proclaimed from on high, Covid is extremely fatal, the injections are extremely safe and effective.
Full stop."
by Sadaf Gilani MD,
a Canadian entrepreneur and activist.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.